Free accessResearch articleFirst published online 2008-7
Effect of Nasal Continuous Positive Airway Pressure Therapy on Health-related Quality of Life in Sleep Apnoea Patients Treated in the Routine Clinical Setting of a University Hospital
The effectiveness and cost-utility of nasal continuous positive airway pressure (nCPAP) treatment was evaluated in obstructive sleep apnoea syndrome (OSAS), using a 15D health-related quality of life (HRQoL) instrument in a routine clinical setting. In total, 78 OSAS patients (43 receiving nCPAP; 35 receiving lifestyle guidance) were included in the study. nCPAP treatment had a minor effect on the total HRQoL score; only the dimension of sleep improved in both groups. The mean ± SD number of quality-adjusted life years (QALYs) gained was 0.016 ± 2.34 in the nCPAP group and 0.386 ± 1.16 in the lifestyle guidance group. The mean cost per QALY gained was €73 375 for the nCPAP group and €845 for the lifestyle guidance group. The effect of nCPAP treatment on the HRQoL in a population of unselected OSAS patients was surprisingly small and the cost per QALY gained was high.
RawlinsMDCulyerAJ: National Institute for Clinical Excellence and its value judgments. BMJ2004; 329: 224–227.
2.
EnglemanHMDouglasNJ: Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax2004; 59: 618–622.
3.
AkashibaTKawaharaSAkahoshiT: Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest2002; 122: 861–865.
4.
PoloOBerthon-JonesMDouglasNJ: Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet1994; 344: 655–660.
5.
KalesACaldwellABCadieuxRJ: Severe obstructive sleep apnea—II: Associated psychopathology and psychosocial consequences. J Chronic Dis1985; 38: 427–434.
6.
GrunsteinRRStenlöfKHednerJA: Impact of self-reported sleep-breathing disturbances on psychosocial performance in the Swedish obese Subjects (SOS) Study. Sleep1995; 18: 635–643.
7.
YoungTPaltaMDempseyJ: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med1993; 328: 1230–1235.
8.
PackAIGurubhagavatulaI: Economic implications of the diagnosis of obstructive sleep apnea. Ann Intern Med1999; 130: 533–534.
9.
WrightJJohnsRWattI: Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: A systematic review of the research evidence. BMJ1997; 314: 851–860.
10.
GoldMRSiegelJERussellLB: Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
11.
JenkinsonCDaviesRJMullinsR: Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea. QJM2001; 94: 95–99.
12.
FlemonsWWReimerMA: Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am J Respir Crit Care Med1998; 158: 494–503.
13.
RäsänenPRoineESintonenH: Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. Int J Technol Assess Health Care2006; 22: 235–241.
14.
TousignantPCosioMGLevyRD: Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep1994; 17: 52–60.
15.
ChakravortyICaytonRMSzczepuraA: Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome. Eur Respir J2002; 20: 1233–1238.
16.
LloberesPMartiSSampolG: Predictive factors of quality-of-life improvement and continuous positive airway pressure use with sleep apnea—hypopnea syndrome: Study at 1 year. Chest2004; 126: 1241–1247.
17.
SannerBMKlewerJTrummA: Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J2000; 16: 118–122.
18.
JenkinsonCStradlingJPetersenS: How should we evaluate health status? A comparison of three methods in patients presenting with obstructive sleep apnoea. Qual Life Res1998; 7: 95–100.
19.
DingliKColemanELVennelleM: Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J2003; 21: 253–259.
20.
SalmiTTelakiviTPartinenM: Evaluation of automatic analysis of SCSB, airflow and oxygen saturation signals in patients with sleep related apneas. Chest1989; 96: 255–261.
SintonenHArinenS-S: The health status of the adult Finnish population as measured by life expectancy, the 15D and QALYs. J Soc Med1997; 34: 182–188.
23.
SintonenH: The 15D instrument of health-related quality of life: Properties and applicationsAnn Med2001; 33: 328–336.
24.
StavemK: Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res1999; 8: 45–54.
25.
HawthorneGRichardsonJDayNA: A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med2001; 33: 358–370.
26.
AromaaAKoskinenS: Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. Helsinki: Publications of the National Public Health Institute, Series B 12/2004, p 171.
27.
Statistical Yearbook of Finland 2003. Helsinki: Statistics Finland, 2003.
28.
SintonenH: The 15-D Measure of Health-related Quality of Life: II. Feasibility, Reliability and Validity of Its Valuation System. Working Paper 42. Melbourne: National Center for Health Program Evaluation, National Health and Medical Research Council, 1995.
29.
MoyerCSonnadSGaretzS: Quality of life in obstructive sleep apnea: A systematic review of the literature. Sleep Med2001; 2: 477–491.
30.
BolitschekJSchmeiser-RiederASchobersbergerR: Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea. Eur Respir J1998; 11: 890–894.
31.
EnglemanHM: When does ‘mild’ obstructive sleep apnea/hypopnea syndrome merit continuous positive airway pressure treatment?Am J Respir Crit Care Med2002; 165: 743–745.
32.
MeslierNLebrunTLanoirV Grillier: A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: Benefits, tolerance, compliance and quality of life. Eur Respir J1998; 12: 185–192.
33.
ProfantJAncoli-IsraelSDimsdaleJE: A randomized, controlled trial of 1 week of continuous positive airway pressure treatment on quality of life. Heart Lung2003; 32: 52–58.
MarJRuedaJRCantollaJ Durán: The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J2003; 21: 515–522.
36.
KauppinenRSintonenHVilkkaV: Quality-of-life measures and clinical parameters in asthmatics during three year follow-up. Monaldi Arch Chest Dis1998; 53: 400–404.
37.
RäsänenPPaavolainenPSintonenH: Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop2007; 78: 108–115.
